Fortress Biotech Inc:
* Avenue Therapeutics prices initial public offering of $33,000,000 of common stock
* Says initial public offering of 5.50 million common shares priced at $6.00per share Source text for Eikon: Further company coverage:
June 26th, 2017 | 20:39 PM market healthcare 166
Fortress Biotech Inc:
* Avenue Therapeutics prices initial public offering of $33,000,000 of common stock
* Says initial public offering of 5.50 million common shares priced at $6.00per share Source text for Eikon: Further company coverage: